Novel technology for the diagnosis and monitoring
of iron toxicity, iron overload, in body fluids

About us

Aferrix is an innovative leader in development and applications of novel tools for early diagnosis and monitoring of toxic iron in the serum. The company has developed several methods that quantify different forms of toxic iron in the serum, which are not detected by conventional tests.

Aferrix offers iron testing services and kits for research and treatment centers that specialize in iron over load diseases (Thalassemia, Hemochromatosis, Myelodysplastic syndrome) and to pharmaceutical companies that are developing iron chelators.

The company was founded by Prof. Zvi Ioav Cabantchik, Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel.

Professor I. Cabantchik, M.D., Ph.D., Founder & Scientific advisor

Prof. Ioav CabantchikProf. Cabantchik is a Professor Emeritusof Biochemistry at the Institute of Life Sciences at the Hebrew University of Jerusalem. His academic research was focused on novel approaches for tracing the status of toxic iron in biological samples, its involvement in iron overload metabolic and neurologic disorders.

Prof. Cabantchik founded Aferrix based on the diagnostic and monitoring technologies he developed. He is a worldwide expert and speaker on Iron metabolism.

In September 2015: Prof. Ioav Cabantchik was elected for the next president of the International BioIron Society (IBIS) and is the 2015 recipient of the Marcel Simon awarded for excellence in research.
His is a graduate of the MD- PhD programme at the University of Rochester School of Medicine, NY, USA

Contact Us